High-throughput in-vitro allergen screening method

An allergen and high-throughput technology, applied in the direction of measuring devices, instruments, scientific instruments, etc., can solve problems affecting specificity and accuracy, false negative results, missed detection, etc., and achieve the effect of improving specificity and accuracy

Inactive Publication Date: 2016-04-20
SUZHOU AILEZHEN MEDICAL EQUIP CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The method used by the UniCAP system of Swedish Pharmacia Company is fluorescent immunological detection, but since the UniCAP system uses patient serum to react with pre-coated and fixed allergens, the specific IgE antibody in the serum binds to the allergen It will be competed by the specific IgG antibody in the serum, so it will bias the test results and affect the specificity and accuracy
[0004]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0018] Embodiments of the invention are described in detail below, but the invention can be practiced in many different ways as defined and covered by the claims.

[0019] The invention provides a high-throughput in vitro allergen screening method, comprising the following steps:

[0020] (1) Extract peripheral blood, separate serum, add it to a 96-well plate that has been pre-coated with mouse or rabbit anti-human IgE antibody and blocked with 1% BSA blocking solution (bovine serum albumin blocking solution), and incubate at 37°C React for 1 hour.

[0021] (2) The allergen-specific IgE antibody and non-specific IgE antibody in the serum are captured by the pre-coated anti-IgE antibody to produce a specific antigen-antibody reaction;

[0022] (3) After incubation, wash with PBS buffer to remove non-specific binding components;

[0023] (4) Add 96 kinds of biotin-labeled specific allergens to one of the 96-well plates, and the specific allergens are combined with the correspo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a high-throughput in-vitro allergen screening method, which comprises: peripheral blood drawing, separating serum, adding the serum into BSA liquid closed 96-well plates pre-coated with mouse or rabbit anti-human IgE antibody in advance to perform incubation; carrying out specific antigen-antibody reaction; after incubation, conducting washing to remove non-specifically bound components; adding 96 biotin labeled specific allergens to one of the 96-well plates respectively; adding a biotin labeled anti-IgE antibody into the other 96-well plate, performing incubation, conducting washing to remove non-specifically bound components; conducting sample adding of fluorescein labeled streptavidin to the 96-well plates, conducting inoculation, and then performing washing; then sending the 96-well plates to a high-throughput fluorescence signal detection system to carry out quantitative detection of the fluorescence intensity respectively, and using the total IgE detected by the first 96-well plate to judge allergy; and using the other 96-well plate to diagnose allergen. The method provided by the invention has an accuracy of effective detection of allergens up to 95%, and can detect more than 90 allergens at a time.

Description

technical field [0001] The invention relates to a high-throughput in vitro allergen screening method. Background technique [0002] Allergic diseases, also known as allergic diseases, refer to tissue damage or physiological functions caused by the stimulation of the body by antigenic substances (also known as allergens or allergens), such as pollen, dust, food, drugs, parasites, etc. Disorder, which is an abnormal or pathological immune response. The fundamental problem to be solved is to first determine what the allergen is? Effective prevention and treatment can only be achieved by accurately identifying the exact allergen to which the patient is allergic. At present, the main allergen screening methods include in vivo detection and in vitro detection. Among them, there are two kinds of in vivo detection methods: skin test method and spot method. The disadvantage is that the body is more painful. In vitro detection is mainly in vitro immunoassay. In vitro immunoassay ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/564
Inventor 路建伟敖星星
Owner SUZHOU AILEZHEN MEDICAL EQUIP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products